Search Results - "Bright, Emilie C"
-
1
Association of Foxp3 regulatory gene expression with graft-versus-host disease
Published in Blood (01-10-2004)“…Graft-versus-host disease (GVHD) is characterized by an impairment of mechanisms that underlie the development of immunologic tolerance. Although the cytokine…”
Get full text
Journal Article -
2
Chemokine Receptor Expression by Leukemic T Cells of Cutaneous T-Cell Lymphoma: Clinical and Histopathological Correlations
Published in Journal of investigative dermatology (01-12-2007)“…Chemokine receptors expressed by normal and neoplastic lymphocytes provide an important mechanism for cells to traffic into the skin and skin-associated lymph…”
Get full text
Journal Article -
3
Unexpected T-cell diversity in syngeneic graft-versus-host disease revealed by interaction with peptide-loaded soluble MHC class II molecules
Published in Transplantation (27-04-2003)“…Administration of cyclosporine after syngeneic bone marrow transplantation elicits a systemic autoaggression syndrome termed syngeneic graft-versus-host…”
Get full text
Conference Proceeding Journal Article -
4
Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon γ may be critical mediators for the development of autologous GVHD
Published in Blood (01-10-2002)“…Administration of the immunosuppressive drug cyclosporine A (CsA) following autologous stem cell transplantation paradoxically elicits a systemic autoimmune…”
Get full text
Journal Article -
5
Functionally divergent T lymphocyte responses induced by modification of a self-peptide from a tumor-associated antigen
Published in Clinical immunology (Orlando, Fla.) (01-03-2005)“…The N- and C-terminal flanking domains of the invariant chain peptide, CLIP, have remarkable immunological properties. Addition of these flanking domains to a…”
Get full text
Journal Article -
6
Characterization of the T-cell repertoire in autologous graft-versus-host disease (GVHD): evidence for the involvement of antigen-driven T-cell response in the development of autologous GVHD
Published in Blood (01-08-2001)“…Administration of cyclosporine A (CsA) after autologous stem cell transplantation elicits an autoimmune syndrome with pathology similar to graft-versus-host…”
Get full text
Journal Article -
7
Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand
Published in Biology of blood and marrow transplantation (01-03-2004)“…The administration of cyclosporin A (CsA) after autologous stem cell transplantation (SCT) paradoxically elicits a systemic autoimmune syndrome that resembles…”
Get full text
Journal Article -
8
Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease
Published in Biology of blood and marrow transplantation (01-09-2004)“…Administration of cyclosporine after autologous bone marrow transplantation elicits a T-lymphocyte autoaggression syndrome with remarkable similarity to…”
Get full text
Journal Article -
9
Post-Transplantation High-Dose Cyclophosphamide (Cy) Is Effective Single Agent GVHD Prophylaxis That Permits Prompt Immune Reconstitution after Myeloablative HLA Matched Related and Unrelated Bone Marrow Transplantation (BMT)
Published in Blood (16-11-2006)“…Prolonged pharmacologic immunosuppression is a major obstacle to early immunologic recovery after allogeneic BMT. Based on our results in animal models, we…”
Get full text
Journal Article -
10
Antigen Specificity and Immunoregulation in Syngeneic Graft-Versus-Host Disease
Published in Blood (16-11-2004)“…Syngeneic graft-vs-host disease (SGVHD) is a T cell dependent autoaggression syndrome induced by administering Cyclosporine following syngeneic bone marrow…”
Get full text
Journal Article -
11
T Cell Activation and Regulation in Graft-Versus-Host Disease: Integral Role of CD28, CTLA4 and GITR Splice Variants
Published in Blood (16-11-2004)“…Graft-versus-host disease (GVHD) is a serious, life-threatening complication that occurs following allogeneic (allo) bone marrow transplantation (BMT). The use…”
Get full text
Journal Article -
12
Specificity of effector T lymphocytes in autologous graft-versus-host disease : Role of the major histocompatibility complex class II invariant chain peptide
Published in Blood (15-03-1997)“…Administration of the immunosuppressive drug cyclosporine after autologous bone marrow transplantation induces a systemic autoimmune syndrome resembling…”
Get full text
Journal Article -
13
Characterization of the autoreactive T cell repertoire in cyclosporin- induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggression
Published in The Journal of immunology (1950) (15-04-1995)“…Syngeneic graft-vs-host disease (SGVHD) is a MHC class II-restricted T cell-mediated autoimmune syndrome that occurs following syngeneic bone marrow…”
Get full text
Journal Article -
14
Characterization of peripheral autoregulatory mechanisms that prevent development of cyclosporin-induced syngeneic graft-versus-host disease
Published in The Journal of immunology (1950) (01-07-1994)“…Administration of cyclosporin after syngeneic bone marrow transplantation paradoxically elicits a T lymphocyte-dependent autoaggression syndrome termed…”
Get full text
Journal Article -
15
Unexpected T-cell diversity in syngeneic graft-versus-host disease revealed by interaction with peptide-loaded soluble MHC class II molecules1
Published in Transplantation (01-04-2003)Get full text
Journal Article -
16
The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine
Published in Transplantation (01-06-1991)“…The effect of the CD28 activation pathway on the immunosuppressive action of CsA was assessed. Human peripheral blood lymphocytes were stimulated with…”
Get more information
Journal Article